LivaNova PLC (LIVN)
60.18
-0.87
(-1.43%)
USD |
NASDAQ |
Jun 03, 16:00
60.18
0.00 (0.00%)
After-Hours: 20:00
LivaNova Enterprise Value: 3.621B for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 31, 2024 | 3.621B |
May 30, 2024 | 3.609B |
May 29, 2024 | 3.590B |
May 28, 2024 | 3.567B |
May 24, 2024 | 3.543B |
May 23, 2024 | 3.531B |
May 22, 2024 | 3.595B |
May 21, 2024 | 3.594B |
May 20, 2024 | 3.634B |
May 17, 2024 | 3.671B |
May 16, 2024 | 3.720B |
May 15, 2024 | 3.738B |
May 14, 2024 | 3.642B |
May 13, 2024 | 3.626B |
May 10, 2024 | 3.678B |
May 09, 2024 | 3.670B |
May 08, 2024 | 3.695B |
May 07, 2024 | 3.733B |
May 06, 2024 | 3.705B |
May 03, 2024 | 3.789B |
May 02, 2024 | 3.723B |
May 01, 2024 | 3.706B |
April 30, 2024 | 3.334B |
April 29, 2024 | 3.357B |
April 26, 2024 | 3.322B |
Date | Value |
---|---|
April 25, 2024 | 3.299B |
April 24, 2024 | 3.345B |
April 23, 2024 | 3.295B |
April 22, 2024 | 3.240B |
April 19, 2024 | 3.149B |
April 18, 2024 | 3.172B |
April 17, 2024 | 3.124B |
April 16, 2024 | 3.195B |
April 15, 2024 | 3.205B |
April 12, 2024 | 3.185B |
April 11, 2024 | 3.243B |
April 10, 2024 | 3.306B |
April 09, 2024 | 3.339B |
April 08, 2024 | 3.277B |
April 05, 2024 | 3.236B |
April 04, 2024 | 3.198B |
April 03, 2024 | 3.236B |
April 02, 2024 | 3.257B |
April 01, 2024 | 3.302B |
March 31, 2024 | 3.344B |
March 28, 2024 | 3.338B |
March 27, 2024 | 3.335B |
March 26, 2024 | 3.255B |
March 25, 2024 | 3.256B |
March 22, 2024 | 3.341B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.934B
Minimum
Mar 23 2020
4.990B
Maximum
Nov 09 2021
3.552B
Average
3.538B
Median
Feb 01 2021
Enterprise Value Benchmarks
Alphatec Holdings Inc | 1.729B |
Masimo Corp | 7.335B |
Tandem Diabetes Care Inc | 3.189B |
iRhythm Technologies Inc | 2.819B |
RxSight Inc | 2.050B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -41.94M |
Revenue (Quarterly) | 294.91M |
Total Expenses (Quarterly) | 278.67M |
EPS Diluted (Quarterly) | -0.78 |
Gross Profit Margin (Quarterly) | 70.32% |
Profit Margin (Quarterly) | -14.22% |
Earnings Yield | -1.00% |
Operating Earnings Yield | 1.23% |
Normalized Earnings Yield | 1.835 |